Quest Diagnostics (DGX) Cash from Investing Activities (2009 - 2026)

Quest Diagnostics (DGX) has 18 years of Cash from Investing Activities data on file, last reported at -$152.0 million in Q1 2026.

• Quarterly Cash from Investing Activities fell 32.17% year-over-year to -$152.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$668.0 million (up 72.73% YoY) and the FY2025 annual result came in at -$631.0 million, up 75.24% from the prior year.
• Cash from Investing Activities rose to -$152.0 million in Q1 2026 per DGX's latest filing, from -$191.0 million in the prior quarter.
• The five-year high for Cash from Investing Activities was -$82.0 million in Q2 2022, with the low at -$1.6 billion in Q3 2024.
• Average Cash from Investing Activities over 5 years is -$290.3 million, with a median of -$169.0 million recorded in 2022.
• Year-over-year, Cash from Investing Activities plunged 1426.17% in 2024 and soared 87.69% in 2025.
• Quest Diagnostics' Cash from Investing Activities stood at -$174.0 million in 2022, then jumped by 34.48% to -$114.0 million in 2023, then slumped by 340.35% to -$502.0 million in 2024, then surged by 61.95% to -$191.0 million in 2025, then gained by 20.42% to -$152.0 million in 2026.
• Business Quant data shows DGX's Cash from Investing Activities at -$152.0 million in Q1 2026, -$191.0 million in Q4 2025, and -$201.0 million in Q3 2025.